Speed Medical Co (EGX:SPMD)
Egypt
· Delayed Price · Currency is EGP 0.3950
0.00 (0.00%)
At close: Apr 22, 2025
Speed Medical Co Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
| Revenue | 60.13 | 60.33 | 120.02 | 63.17 | 33.09 |
| Revenue Growth (YoY) | -0.34% | -49.73% | 90.00% | 90.91% | - |
| Cost of Revenue | 90.26 | 79.42 | 142.18 | 33.52 | 15.23 |
| Gross Profit | -30.13 | -19.09 | -22.16 | 29.65 | 17.86 |
| Selling, General & Admin | 28.97 | 37.85 | 76.01 | 5.46 | 3.12 |
| Other Operating Expenses | - | - | 5.03 | 0.71 | - |
| Operating Expenses | 40.92 | 54.39 | 105.9 | 11.82 | 5.81 |
| Operating Income | -71.05 | -73.48 | -128.06 | 17.83 | 12.05 |
| Interest Expense | -3.18 | -20.8 | -19.51 | -1.29 | -0.33 |
| Interest & Investment Income | 5.55 | 0.83 | 0.83 | - | - |
| Other Non Operating Income (Expenses) | -15.2 | 5.73 | 1.27 | - | - |
| EBT Excluding Unusual Items | -83.89 | -87.72 | -145.47 | 16.54 | 11.71 |
| Gain (Loss) on Sale of Assets | 0.05 | - | - | - | - |
| Asset Writedown | - | - | -3.74 | - | - |
| Pretax Income | -83.83 | -87.72 | -149.21 | 16.54 | 11.71 |
| Income Tax Expense | -3.55 | -1.23 | -1 | 3.81 | 2.64 |
| Earnings From Continuing Operations | -80.28 | -86.49 | -148.21 | 12.73 | 9.08 |
| Minority Interest in Earnings | - | 2.44 | 2.04 | - | - |
| Net Income | -80.28 | -84.05 | -146.18 | 12.73 | 9.08 |
| Net Income to Common | -80.28 | -84.05 | -146.18 | 12.73 | 9.08 |
| Net Income Growth | - | - | - | 40.18% | - |
| Shares Outstanding (Basic) | 1,673 | 1,664 | 1,109 | 71 | 45 |
| Shares Outstanding (Diluted) | 1,673 | 1,664 | 1,109 | 71 | 45 |
| Shares Change (YoY) | 0.53% | 50.00% | 1455.00% | 59.17% | - |
| EPS (Basic) | -0.05 | -0.05 | -0.13 | 0.18 | 0.20 |
| EPS (Diluted) | -0.05 | -0.05 | -0.13 | 0.18 | 0.20 |
| EPS Growth | - | - | - | -11.93% | - |
| Free Cash Flow | 3.9 | -11.34 | -37.14 | -24.09 | -16.91 |
| Free Cash Flow Per Share | 0.00 | -0.01 | -0.03 | -0.34 | -0.38 |
| Gross Margin | -50.11% | -31.64% | -18.47% | 46.93% | 53.98% |
| Operating Margin | -118.17% | -121.79% | -106.70% | 28.22% | 36.41% |
| Profit Margin | -133.52% | -139.31% | -121.80% | 20.15% | 27.44% |
| Free Cash Flow Margin | 6.48% | -18.79% | -30.95% | -38.14% | -51.10% |
| EBITDA | -53.08 | -72.64 | -127.22 | 23.26 | 14.71 |
| EBITDA Margin | -88.28% | -120.39% | -106.00% | 36.82% | 44.45% |
| D&A For EBITDA | 17.97 | 0.84 | 0.84 | 5.43 | 2.66 |
| EBIT | -71.05 | -73.48 | -128.06 | 17.83 | 12.05 |
| EBIT Margin | -118.17% | -121.79% | -106.70% | 28.22% | 36.41% |
| Effective Tax Rate | - | - | - | 23.04% | 22.50% |
| Advertising Expenses | - | 1.26 | 6.62 | - | - |
Updated Mar 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.